Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling

A Sharma, H Khan, TG Singh, AK Grewal… - International Journal of …, 2021 - mdpi.com
The ubiquitin-proteasome pathway (UPP) is involved in regulating several biological
functions, including cell cycle control, apoptosis, DNA damage response, and apoptosis. It is …

[HTML][HTML] The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy

Y Yang, M Zhang, Y Wang - Journal of the National Cancer Center, 2022 - Elsevier
Histone modifications are key factors in chromatin packaging, and are responsible for gene
regulation during cell fate determination and development. Abnormal alterations in histone …

Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis

S Xing, F Nong, Y Wang, D Huang, J Qin… - Pharmacological …, 2022 - Elsevier
Abstract Skp1-Cul1-F-box protein (SCF) ubiquitin E3 ligases play important roles in cancer
development and serve as a promising therapeutic target in cancer therapy. Brusatol (Bru), a …

The interplay of Rac1 activity, ubiquitination and GDI binding and its consequences for endothelial cell spreading

J Majolée, F Podieh, PL Hordijk, I Kovačević - PLoS One, 2021 - journals.plos.org
Signaling by the Rho GTPase Rac1 is key to the regulation of cytoskeletal dynamics, cell
spreading and adhesion. It is widely accepted that the inactive form of Rac1 is bound by Rho …

Inhibition of NEDD8 NEDDylation induced apoptosis in acute myeloid leukemia cells via p53 signaling pathway

Y Chen, L Sun - Bioscience Reports, 2022 - portlandpress.com
MLN4924 is a potent and selective small-molecule inhibitor of NEDD8-activating enzyme,
which showed antitumor effect in several types of malignant tumor types. However, the …

[HTML][HTML] Targeting cullin neddylation for cancer and fibrotic diseases

ZX He, W Yang, D Zengyangzong, G Gao, Q Zhang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Protein neddylation is a post-translational modification, and its best recognized substrates
are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs) …

A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy

I Bano, M Malhi, M Zhao, L Giurgiulescu, H Sajjad… - 3 Biotech, 2022 - Springer
The cullin-RING E3 ligases (CRLs) are the biggest components of the E3 ubiquitin ligase
protein family, and they represent an essential role in various diseases that occur because …

CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcription

LQ Yang, HY Hu, Y Han, ZY Tang, J Gao… - Cancer Gene …, 2022 - nature.com
Epigenetic alterations have been functionally linked to ovarian cancer development and
occurrence. The CXXC zinc finger protein 1 (CFP1) is an epigenetic regulator involved in …

Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy

J Di Gregorio, L Di Giuseppe, S Terreri, M Rossi… - Cells, 2024 - mdpi.com
The identification of new therapeutic targets and the development of innovative therapeutic
approaches are the most important challenges for osteosarcoma treatment. In fact, despite …

Angiogenesis: Promising therapeutic target of metastatic colon cancer

RR Malla, R Marni - Critical Reviews™ in Oncogenesis, 2020 - dl.begellhouse.com
Colon cancer (CC) is the third most diagnosed cancers globally and second most lethal
malignancy in both men and women due to aggressive metastatic ability. Genetic or somatic …